Newcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi Post author:Sam Post published:January 31, 2018 Post category:BioPharma Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi. Source: BioSpace You Might Also Like Pharma Execs are Attractive Candidates for Healthcare Leadership Roles March 22, 2018 Why Boston-Bound Alexion Could be a Compelling M&A for Larger Drugmakers January 29, 2018 Vaxil BioTherapeutics To Present At BIO CEO & Investor Conference February 13 – 14, 2017 February 9, 2017
Vaxil BioTherapeutics To Present At BIO CEO & Investor Conference February 13 – 14, 2017 February 9, 2017